Cesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock
November 28, 2017 17:20 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent
November 28, 2017 07:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing today announced that on November 21, 2017, the U.S....
Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development
November 22, 2017 07:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update
November 14, 2017 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017
November 14, 2017 07:30 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th
November 07, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation
October 03, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa
September 27, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017
September 25, 2017 13:23 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update
September 19, 2017 16:05 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...